WS12.3 Educational needs for transplanted cystic fibrosis patients

Veríssimo, David; Berville, C.; Ravilly, S.

doi:10.1016/s1569-1993(12)60087-3

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some learning objectives are crucial and should be acquired between the time of transplant and the first return home ( Table 6 ) [ 189 , 190 ]. Detailed explanations should be provided as to the mechanism of action/absorption of immunosuppressive drugs and their anticipated side effects, the need for prophylactic anti-infectious therapy, and drug-drug and drug-food interactions.…”

Section: Other Topicsmentioning

confidence: 99%

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis

Hirche¹,

Knoop

Hebestreit

et al. 2014

Pulmonary Medicine

View full text Add to dashboard Cite

There are no European recommendations on issues specifically related to lung transplantation (LTX) in cystic fibrosis (CF). The main goal of this paper is to provide CF care team members with clinically relevant CF-specific information on all aspects of LTX, highlighting areas of consensus and controversy throughout Europe. Bilateral lung transplantation has been shown to be an important therapeutic option for end-stage CF pulmonary disease. Transplant function and patient survival after transplantation are better than in most other indications for this procedure. Attention though has to be paid to pretransplant morbidity, time for referral, evaluation, indication, and contraindication in children and in adults. This review makes extensive use of specific evidence in the field of lung transplantation in CF patients and addresses all issues of practical importance. The requirements of pre-, peri-, and postoperative management are discussed in detail including bridging to transplant and postoperative complications, immune suppression, chronic allograft dysfunction, infection, and malignancies being the most important. Among the contributors to this guiding information are 19 members of the ECORN-CF project and other experts. The document is endorsed by the European Cystic Fibrosis Society and sponsored by the Christiane Herzog Foundation.

show abstract

Section: Other Topicsmentioning

confidence: 99%